Therapix Biosciences (Israel) Alpha and Beta Analysis

TRPX -- Israel Stock  

null 33.70  0.70  2.12%

This module allows you to check different measures of market premium for Therapix Biosciences Ltd as well as systematic risk associated with investing in Therapix Biosciences over a specified time horizon. Also please take a look at World Market Map.
Horizon     30 Days    Login   to change
Symbol
Run Premiums

Therapix Biosciences Market Premiums

α0.00   β0.00
30 days against DJI

Therapix Biosciences Fundamentals

    
 Better Than Average     
    
 Worse Than Average Compare Therapix Biosciences to competition

Therapix Biosciences Fundamental Vs Peers

FundamentalsTherapix BiosciencesPeer Average
Return On Equity(216.64)%
Return On Asset(37.65)%
Current Valuation58.23M
Shares Outstanding139.89M
EBITDA(7.24M)
Net Income(7.66M)
Cash and Equivalents7.51M

Therapix Biosciences Opportunities

Therapix Biosciences Return and Market Media

The median price of Therapix Biosciences for the period between Mon, Feb 18, 2019 and Fri, Apr 19, 2019 is 31.4 with a coefficient of variation of 58.97. The daily time series for the period is distributed with a sample standard deviation of 14.56, arithmetic mean of 24.69, and mean deviation of 12.34. The Stock received some media coverage during the period.
 Price Growth (%)  
      Timeline 
1
Therapix Biosciences Signs Term Sheet for the Transfer of No...07/12/2018
2
Stock to Follow First Mid-Illinois Bancshares, Inc. ,Therapi...07/29/2018

Search macroaxis.com